Frequency of HPRT gene mutations induced by N-methyl-N'-nitro-N-nitrosoguanidine corresponds to replication error phenotypes of cell lines

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 398, Issue 1-2, 1998, Pages 93-99

  Zhu, Weibin ^a   Yamasaki, Hiroshi ^a   Mironov, Nikolai ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

HPRT; Mismatch repair; MNNG; Mutation; RER

Indexed keywords

CARCINOGEN; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; METHYLNITRONITROSOGUANIDINE; MUTAGENIC AGENT;

ARTICLE; CELL CYCLE; CELL LINE; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; GENE MUTATION; HELA CELL; HUMAN; HUMAN CELL; MUTAGENICITY; MUTATION RATE; PHENOTYPE; PRIORITY JOURNAL; SPONTANEOUS MUTATION;

CELL LINE; DNA REPLICATION; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; METHYLNITRONITROSOGUANIDINE; MUTAGENS; MUTATION; PHENOTYPE;

EID: 0032574334     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(97)00244-3     Document Type: Article

References (32)

1. Aaltonen L.A., Peltomaki P., Leach F.S., Sistonen P., Pylkkanen L., Mecklin J.P., Jarvinen H., Powell S.M., Jean J., Hamilton S.R.et al. Clues to the pathogenesis of familial colorectal cancer. Science. 260:1993;812-816.
2. n DNA repeats and tumor suppressor genes in human gastric cancer. Cancer Res. 54:1994;41-44.
3. Hibi K., Kondo K., Akiyama S., Ito K., Takagi H. Frequent genetic instability in small intestinal carcinomas. Jpn. J. Cancer Res. 86:1995;357-360.
4. Merlo A., Mabry M., Gabrielson E., Vollmer R., Baylin S.B., Sidransky D. Frequent microsatellite instability in primary small cell lung cancer. Cancer Res. 54:1994;2098-2101.
5. Yee C.J., Roodi N., Verrier C.S., Parl F.F. Microsatellite instability and loss of heterozygozity in breast cancer. Cancer Res. 54:1994;1641-1644.
6. Mironov N.M., Aguelon A.-M., Hollams E., Lozano J.-C., Yamasaki H. Microsatellite alterations in human and rat esophageal tumors at selective loci. Mol. Carcinogen. 13:1995;1-5.
7. Karran P. Microsatellite instability and DNA mismatch repair in human cancer. Semin. Cancer Biol. 7:1996;15-24.
8. Acharya S., Wilson T., Gradia S., Kane M.F., Guerrette S., Marsischky G.T., Kolodner R., Fishel R. hMSH2 forms specific mispair-binding complexes with hMSH3 and hMSH6. Proc. Natl. Acad. Sci. USA. 93:1996;13629-13634.
9. Guo-Min L., Modrich P. Restoration of mismatch repair to nuclear extracts of H6 colorectal tumor cells by a heterodimer of human MutL homologs. Proc. Natl. Acad. Sci. USA. 92:1995;1950-1954.
10. + tumor cells. Cell. 75:1993;1227-1236.
11. Bhattacharyya N.P., Skandalis A., Ganesh A., Groden J., Meuth M. Mutator phenotypes in human colorectal carcinoma cell lines. Proc. Natl. Acad. Sci. USA. 91:1994;6319-6323.
12. Eshleman J.R., Lang E.Z., Bowerfind G.K., Parsons R., Vogelstein B.et al. Increased mutation rates at the HPRT locus accompanies microsatellite instability in colon cancer. Oncogene. 10:1995;33-37.
13. Malkhosyan S., McCarty A., Sawai H., Perucho S. Differences in the spectrum of spontaneous mutations in the HPRT gene between tumor cells of the microsatellite mutator phenotype. Mutation Res. 316:1996;249-259.
14. Huang J., Papadopoulos N., McKinley A.J., Farrington S.M., Curtis L.J., Wyllie A.H., Zheng S., Willson J.K.V., Markowitz S.D., Morin P., Kinzler K.W., Vogelstein B., Dunlop M.G. APC mutations in colorectal tumors with mismatch repair deficiency. Proc. Natl. Acad. Sci. USA. 93:1996;9049-9054.
15. Xiao W., Samson L. In vivo evidence for endogenous DNA alkylation damage as a source of spontaneous mutation in eukaryotic cells. Proc. Natl. Acad. Sci. USA. 90:1993;2117-2121.
16. Yang J.-L., Hu M.-C., Wu C.-W. Novel mutational spectrum induced by N-methyl-N′-nitro-N-nitrosoguanidine in the coding region of the hypoxanthine (guanine) phosphoribosyltransferase gene in diploid human fibroblasts. J. Mol. Biol. 221:1991;421-430.
17. 4-methylthumine, or the cisplatin-d(GpG) adduct. Proc. Natl. Acad. Sci. USA. 93:1996;6443-6447.
18. Aquilina G., Hess P., Fiumicino S., Ceccotti S., Bignami M. A mutator phenotype characterizes one of two complementation groups in human cells tolerant to methylation damage. Cancer Res. 55:1995;2569-2575.
19. Kat A., Thilly W.G., Fang W.-H., Longley M.J., Guo-Min L., Modrich P. An alkyaltion-tolerant, mutator human cell line is deficient in strand-specific mismatch repair. Proc. Natl. Acad. Sci. USA. 90:1993;6424-6428.
20. Aquilina G., Hess P., Branch P., MacGeoch C., Casciano I., Karran P., Bignami M. A mismatch recognition defect in colon carcinoma confers DNA microsatellite instability and a mutator phenotype. Proc. Natl. Acad. Sci. USA. 91:1994;8905-8909.
21. Aebi S., Kurdi-Haidar B., Gordon R., Cenni B., Zheng H., Fink D., Christen R.D., Boland R.C., Koi M., Fishel R., Howell S.F. Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Res. 56:1996;3087-3090.
22. Glaab W.E., Tindall K.R. Mutation rate at the HPRT locus in human cancer cell lines with specific mismatch repair-gene defects. Carcinogenesis. 18:1997;1-8.
23. Davidson J.S., Baumgarten I.M., Harley E.H. Reversible inhibition of intercellular junctional communication by glycyrrhetinic acid. Biochem. Biophys. Res. Commun. 134:1986;29-36.
24. Bhattacharyya N.P., Ganesh A., Phear G., Richards B., Skandalis A., Meuth M. Molecular analysis of mutations in mutator colorectal carcinoma cell lines. Hum. Mol. Genet. 4:1995;2057-2064.
25. Branch P., Hampson R., Karran P. DNA mismatch binding defects, DNA damage tolerance, and mutator phenotypes in human colorectal carcinoma cell lines. Cancer Res. 55:1995;2304-2309.
26. Goldmacher V.S., Cuzick R.A. Jr., Thilly W.G. Isolation and partial characterization of human cell mutants differing in sensitivity to killing and mutation by methylnitrosourea and N-methyl-N′-nitro-N-nitrosoguanidine. J. Biol. Chem. 261:1986;12462-12471.
27. Karran P., Bignami M. DNA damage tolerance, mismatch repair and genome instability. Bioessays. 16:1994;833-839.
28. Galloway S.M., Greenwood S.K., Hill R.B., Bradt C.I., Bean C.L. A role for mismatch repair in production of chromosome aberrations by methylating agents in human cells. Mutation Res. 346:1995;231-245.
29. Black K.A., McFarland R.D., Grisham J.W., Smith G.J. Cell cycle perturbation and cell death after exposure of a human lymphoblastoid cell strain to N-methyl-N′-nitro-N-nitrosoguanidine. Am. J. Pathol. 134:1989;53-61.
30. Carethers J.M., Hawn M.T., Chauhan D.P., Luce M.C., Marra G., Koi M., Boland C.R. Competency in mismatch repair prohibits clonal expansion of cancer cells treated with N-methyl-N′-nitro-N-nitrosoguanidine. J. Clin. Invest. 98:1996;199-206.
31. 6-alkylguanine-DNA alkyltransferase activity. Br. J. Cancer. 74:1996;1030-1036.
32. + status and p53 mutation in colorectal cancer cell lines. Oncogene. 13:1996;2727-2730.